Plain-English translation of NCT04688411 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a smartphone app called MED-Go to help young people with sickle cell disease stick with their medication routine. Sickle cell disease is a serious genetic blood disorder that causes pain and other health complications, and hydroxyurea is an important FDA-approved medication that reduces these problems—but many young people struggle to take it regularly. The study wants to see if the app makes it easier and more acceptable for teenagers and young adults to remember and take their medication every day.
Many young people with sickle cell disease don't take their medication consistently enough to get its full benefits, partly because they're juggling school, social life, and other priorities. This medication can prevent serious complications and improve quality of life, so researchers want to test whether a mobile app—something young people already use every day—can help them stay on track with their treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly placed into one of two groups: one will use the MED-Go app for 12 weeks to help track and remind you about your medication, while the other will continue with standard care. The study is specifically looking at whether the app is easy to use and whether young people find it helpful, so your feedback will be important. The entire study lasts 12 weeks, and researchers will stay in touch to see how you're doing.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States